A new trading day began on Tuesday, with Capricor Therapeutics Inc (NASDAQ: CAPR) stock price down -3.60% from the previous day of trading, before settling in for the closing price of $30.04. CAPR’s price has ranged from $4.30 to $40.37 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 11.01%. Meanwhile, its annual earnings per share averaged -85.39%. With a float of $47.82 million, this company’s outstanding shares have now reached $54.40 million.
Capricor Therapeutics Inc (CAPR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Capricor Therapeutics Inc is 12.11%, while institutional ownership is 31.98%.
Capricor Therapeutics Inc (CAPR) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.16 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -85.39% per share during the next fiscal year.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Here are Capricor Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 141.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach 0.32 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Compared to the last year’s volume of 2.13 million, its volume of 0.83 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 80.71%.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 68.37%, which indicates a significant increase from 65.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.53 in the past 14 days, which was higher than the 0.96 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.28, while its 200-day Moving Average is $10.35. Nevertheless, the first resistance level for the watch stands at $29.97 in the near term. At $30.97, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.86. If the price goes on to break the first support level at $28.08, it is likely to go to the next support level at $27.19. Now, if the price goes above the second support level, the third support stands at $26.19.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
With a market capitalization of 1.58 billion, the company has a total of 45,718K Shares Outstanding. Currently, annual sales are 22,270 K while annual income is -40,470 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,570 K.
